News

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on ...
President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.
In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...
Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...
At a Cabinet meeting earlier this month, Trump said that he expected pharmaceutical tariffs to grow as high as 200% after ...
The sector-specific tariffs are putting pressure on businesses and foreign nations as they try to navigate Trump’s constantly ...
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...
Trump plans steep tariffs on pharmaceuticals and semiconductors by July-end, eyes India trade deal as part of broader ...
Australia is “urgently seeking more detail” on U.S. President Donald Trump’s threat to raise tariffs up to 200% on ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.